Specifically, miR-17-5p was delivered to CRC cells via CRC stem cell-derived sEVs and increased PD-L1 expression by inhibiting SPOP, which in turn suppressed anti-tumor immunity and promoted the growth of CRC cells. This evidence concerns the gene CD274 and colorectal carcinoma.